Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
6/15/2023
Health Technology Assessment to Inform Decision Making in China: Progr...
6/14/2023
Simcere Pharma Announces Sponsored Research Agreement with Boston-base...
6/14/2023
AstraZeneca's Soliris Approved in China to Treat gMG
6/13/2023
Eikon Therapeutics In-licenses Novel Immune Modulator Agonist from Sev...
6/13/2023
Innocare Inches Closer to Profitability on Strong Sales Gains (Bamboo ...
6/13/2023
NMPA Announces Package Insert Revision of Betahistine Preparations
6/13/2023
Responding to Challenges in the Chinese Healthcare Market Volume Based...
6/12/2023
China's Growth as Pharmaceutical Hub for APIs to Continue (BioSpectrum...
6/12/2023
China Wakes Up to Danger From Illegal Lab Monkey Trade (Sixth Tone)
6/12/2023
Understanding China's Rapidly Growing Healthcare Market (China Briefin...
6/12/2023
China's BMI Fund Income and Expenditure Up 8.1% and 23.1% in First Fo...
6/12/2023
China Announces 81 Pilot Regions for Integrated Medical Services
6/9/2023
Biomarin Reportedly Not to Renew Import Drug License of Orphan Drug Vi...
6/9/2023
NHC Solicits Comments on the Proposed Biosafety Standards for Vaccine ...
6/9/2023
CDE Publicizes the List of Reference Formulations for GQCE Studies (71...
6/9/2023
CDE Issues the Technical Guidelines for Clinical Trial Design of New N...
6/9/2023
NHSA Releases the Draft Working Plan and the Application Guide for Adj...
6/9/2023
Recent Executive Moves
6/9/2023
Drug R&D and Product Registration News Digest June 2023 (2)
6/9/2023
May Was a Big Month for Oncology Therapies in China (PharmaDJ)
6/8/2023
How China's Detailed Human Genetic Resources Rules May Impact MNC Life...
6/7/2023
Chinese Drugmakers Seek to Emulate the Success of Novo Nordisk's Wegov...
6/7/2023
Fosun Pharma to Build African Drug Manufacturing Plant with Help from ...
6/6/2023
NH: China CHC Growth Slows in 2022 vs 2021
6/5/2023
Aurobindo Pharma Completes Plant Installation in China
6/5/2023
Ozempic Frenzy Hitting China as the Country Prepares to Approve It for...
6/5/2023
Chinese Pharma Performance A Mix Bag This Year as the Country Renews C...
6/5/2023
China Races into New-Generation Obesity Drug Arena with Potential Asse...
6/5/2023
AstraZeneca Defies Geopolitics to Bet on China (FT)
6/5/2023
British Businesses in China: Conditionally Optimistic for 2023 (China ...
Page:
100
/
775
Total number of articles:
23243
:
[First]
[<<]
[98]
[99]
[100]
[101]
[102]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit